Anticoagulation Management Service
Other
≈ ¥20-50
(≈ $3-7)
15 min
Disclaimer: This site is a medical service platform; some page content is AI-assisted. Health-related information does not constitute medical advice. If you have any questions, please consult a healthcare professional. See full disclaimer
Description
Estimated cost for Anticoagulation Management Service at general public hospitals in China is about ¥15-40, and at Grade 3A hospitals about ¥20-50, varying by hospital tier and region.
Main Uses
Ensures safe and effective long-term anticoagulation therapy through structured outpatient monitoring; includes INR measurement and interpretation, medication dose titration, drug–drug/food interaction counseling, bleeding/thrombosis risk assessment, patient adherence support, and documentation for regulatory compliance. Used primarily for patients on vitamin K antagonists (e.g., warfarin), direct oral anticoagulants (DOACs) in complex cases, mechanical heart valves, atrial fibrillation, VTE prophylaxis/treatment, and antiphospholipid syndrome.
Normal Range
Not applicable — 'Anticoagulation Clinic Follow-up Management Fee' is not a laboratory test with numerical values; it is a healthcare service charge for clinical monitoring, dose adjustment, INR interpretation, patient education, and safety assessment during oral anticoagulant therapy (e.g., warfarin). No biological reference range exists.
Low Values - Possible Causes
N/A — This is a billing/management fee, not a physiological parameter; therefore, 'low values' have no clinical or biological meaning. Fee amounts may vary by institution but do not reflect patient health status.
High Values - Possible Causes
N/A — This is a standardized or regulated service fee; 'high values' refer only to pricing variations due to regional healthcare policies, visit complexity (e.g., unstable INR, polypharmacy, bleeding risk), extended counseling time, or inclusion of point-of-care INR testing — not pathological conditions.